T Cell Receptors (TCRs) constitute one of the most promising classes of emerging therapeutics. Whilst TCRs are amongst the most complex facets of immune biology, engineering of an optimum T Cell Receptor can transform immunotherapies and personalised medicines.

Etcembly is building the world’s largest machine learning database and unmatched immunology expertise to deliver the safest and most powerful TCR immunotherapies through rapid computer-assisted engineering.

Address

Atlas Building Harwell Campus Oxfordshire OX11 0QX

Other organisations on campus